Novamox CV DS (30 ml) Syrup

Novamox CV DS (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Cipla Limited. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Amoxycillin, Clavulanic Acid. This drug comes in the form of Syrup. The general packing available for this medicine consists of 30 ml and is priced at Rs 70 (arround $0.98 US Dollar)
Generic (Salt) Combination :(Amoxycillin+ Clavulanic Acid)
Pharma Company :Cipla Limited
Brand Label :Novamox CV DS (30 ml)
Preparation Type :Syrup
Single Dose :5 ml
Composition (Fixed-Dose Combination) :
  • Clavulanic Acid-28.5 mg
  • Amoxycillin-200 mg
Pack Size/Qty/Vol :30 ml
Price Unit :Rs 11.67 INR (arround $0.16338 US Dollar)
Price Pack :Rs 70 INR (arround $0.98 US Dollar)

Drug details for Novamox CV DS (30 ml)

Usage: Why is this medication prescribed?

The main active ingredients or salts in Novamox CV DS (30 ml) are :

  • Clavulanic Acid-28.5 mg
  • Amoxycillin-200 mg

Amoxycillin
Indication (Prescribed for or used as): Respiratory, genito-urinary, skin and soft tissue, ENT infections due to susceptible strains of Gram negative organisms like H.influenzae, E-coli, P.mirabilis and N. gonorrhoea. Gram positive organisms like streptococci (including streptococcus faecalis) D. pneumoniae and non-penicillase producing staphylococci.

For more details on Amoxycillin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Amoxycillin..

Clavulanic Acid
Indication (Prescribed for or used as):

For more details on Clavulanic Acid, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Clavulanic Acid..

Novamox CV DS (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :

There are 56 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Novamox CV DS (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Clavulanic Acid-28.5 mg Amoxycillin-200 mg).
Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.

BrandPrice (Rs.)BrandPrice (Rs.)
A Clas (30 ml) 63AC 2 (30 ml) 65
Aceclav DS (200+28.5) 42Afymox Clav DS (30 ml) 78
Akniclav Plus (30 ml) 65Alepam DT (200+28.5) 1 400.00
Alnos CV (30 ml) 70Amofix (30 ml) 78
Amoxyrich CV (30 ml) 55Amzeclav (30 ml) 65
Ariclav DS (30 ml) 76.5Athoclav (30 ml) 79.9
Axymox CL (200+28.5) 72Betmox CV (30 ml) 55
Bilclav Duo (30 ml) 69.9Cadmentin (30 ml) 76.65
Clamchek BD (30 ml) 65Clamox (30 ml) (Hamax) 67.8
Clavactum DS (20 ml) 77.7Clavactum Susp (30 ml) 72
Clavbel (30 ml) 70Claver (30 ml) 67
Clavoxy (30 ml) 61Clavserch DS (30 ml) 62
Co Clav DS (30 ml) 59CO Symoxyl (30 ml) 49
Cobex CL (30 ml) 67Dotclav (30 ml) 72
Duet DS (30 ml) 75Erifix CV (30 ml) 58
Indclav DT (200+28.5) 76.5Joyclav DT (200+28.5) 120
Keptin DS (30 ml) 54Krusade DS (30 ml) 73.5
Lavan A (30 ml) 65M Clav (30 ml) 68.6
Manox Clav DS (30 ml) 65Medclav (30 ml) 55
Mikclav (30 ml) 72MInoclav DT (200+28.5) 79.5
Moxila (30 ml) 45Moxileb CV DT (200+28.5) 79.4
Moxiz CV (30 ml) 69Moxxil Duo (200+28.5) 60
Nexximox CV Duo (30 ml) 55Nomclox Clav (30 ml) 78
Prin CV (30 ml) 98Pureclav (30 ml) 72
R Clav (30 ml) 78Renmox CL (30 ml) 82.5
SP Clav DT (200+28.5) 40Taurmox C (200+28.5) 63
Voyclav (200+28.5) 1 400.00Welclave (30 ml) 65
Xoclave (30 ml) 40Xoclave DT (200+28.5) 50

Search Drug Brands alphabetically